153 related articles for article (PubMed ID: 32903632)
1. Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink.
Hangasky JA; Waldmann TA; Santi DV
Front Immunol; 2020; 11():1813. PubMed ID: 32903632
[TBL] [Abstract][Full Text] [Related]
2. A very long-acting IL-15: implications for the immunotherapy of cancer.
Hangasky JA; Chen W; Dubois SP; Daenthanasanmak A; Müller JR; Reid R; Waldmann TA; Santi DV
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101947
[TBL] [Abstract][Full Text] [Related]
3. Complex PK-PD of an engineered IL-15/IL-15Rα-Fc fusion protein in cynomolgus monkeys: QSP modeling of lymphocyte dynamics.
Lu D; Yadav R; Holder P; Chiang E; Sanjabi S; Poon V; Bernett M; Varma R; Liu K; Leung I; Bogaert L; Desjarlais J; Shivva V; Hosseini I; Ramanujan S
Eur J Pharm Sci; 2023 Jul; 186():106450. PubMed ID: 37084985
[TBL] [Abstract][Full Text] [Related]
4. Effects of route and formulation on clinical pharmacokinetics of interleukin-2.
Anderson PM; Sorenson MA
Clin Pharmacokinet; 1994 Jul; 27(1):19-31. PubMed ID: 7955769
[TBL] [Abstract][Full Text] [Related]
5. IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.
Patil NK; Luan L; Bohannon JK; Guo Y; Hernandez A; Fensterheim B; Sherwood ER
PLoS One; 2016; 11(2):e0148452. PubMed ID: 26859674
[TBL] [Abstract][Full Text] [Related]
6. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques.
Villinger F; Miller R; Mori K; Mayne AE; Bostik P; Sundstrom JB; Sugimoto C; Ansari AA
Vaccine; 2004 Sep; 22(25-26):3510-21. PubMed ID: 15308379
[TBL] [Abstract][Full Text] [Related]
7. The potential and promise of IL-15 in immuno-oncogenic therapies.
Robinson TO; Schluns KS
Immunol Lett; 2017 Oct; 190():159-168. PubMed ID: 28823521
[TBL] [Abstract][Full Text] [Related]
8. IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.
Conlon KC; Potter EL; Pittaluga S; Lee CR; Miljkovic MD; Fleisher TA; Dubois S; Bryant BR; Petrus M; Perera LP; Hsu J; Figg WD; Peer CJ; Shih JH; Yovandich JL; Creekmore SP; Roederer M; Waldmann TA
Clin Cancer Res; 2019 Aug; 25(16):4945-4954. PubMed ID: 31142503
[TBL] [Abstract][Full Text] [Related]
9. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Conlon KC; Lugli E; Welles HC; Rosenberg SA; Fojo AT; Morris JC; Fleisher TA; Dubois SP; Perera LP; Stewart DM; Goldman CK; Bryant BR; Decker JM; Chen J; Worthy TA; Figg WD; Peer CJ; Sneller MC; Lane HC; Yovandich JL; Creekmore SP; Roederer M; Waldmann TA
J Clin Oncol; 2015 Jan; 33(1):74-82. PubMed ID: 25403209
[TBL] [Abstract][Full Text] [Related]
10. IL-15 and HIV infection: lessons for immunotherapy and vaccination.
Ahmad A; Ahmad R; Iannello A; Toma E; Morisset R; Sindhu ST
Curr HIV Res; 2005 Jul; 3(3):261-70. PubMed ID: 16022657
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist.
Chang CM; Lo CH; Shih YM; Chen Y; Wu PY; Tsuneyama K; Roffler SR; Tao MH
Hum Gene Ther; 2010 May; 21(5):611-21. PubMed ID: 20064014
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
[TBL] [Abstract][Full Text] [Related]
14. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15.
Kobayashi H; Carrasquillo JA; Paik CH; Waldmann TA; Tagaya Y
Cancer Res; 2000 Jul; 60(13):3577-83. PubMed ID: 10910071
[TBL] [Abstract][Full Text] [Related]
15. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models.
Liu B; Jones M; Kong L; Noel T; Jeng EK; Shi S; England CG; Alter S; Miller JS; Cai W; Rhode PR; Wong HC
Cytokine; 2018 Jul; 107():105-112. PubMed ID: 29452720
[TBL] [Abstract][Full Text] [Related]
17. IL-15/IL-15 receptor biology: a guided tour through an expanding universe.
Budagian V; Bulanova E; Paus R; Bulfone-Paus S
Cytokine Growth Factor Rev; 2006 Aug; 17(4):259-80. PubMed ID: 16815076
[TBL] [Abstract][Full Text] [Related]
18. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
Soiffer RJ; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
Clin Cancer Res; 1996 Mar; 2(3):493-9. PubMed ID: 9816195
[TBL] [Abstract][Full Text] [Related]
19. New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.
Bailey CP; Budak-Alpdogan T; Sauter CT; Panis MM; Buyukgoz C; Jeng EK; Wong HC; Flomenberg N; Alpdogan O
Oncotarget; 2017 Jul; 8(27):44366-44378. PubMed ID: 28574833
[TBL] [Abstract][Full Text] [Related]
20. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]